Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
The last decade has witnessed revolutionary advances taken in immunotherapy for various malignant tumors. However, immune-related molecules and their characteristics in the prediction of clinical outcomes and immunotherapy response in clear cell renal cell carcinoma (ccRCC) remain largely unclear. C...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/682895e2e2d84a859f1a0827826e7a6f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:682895e2e2d84a859f1a0827826e7a6f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:682895e2e2d84a859f1a0827826e7a6f2021-11-30T18:58:50ZIdentification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma2234-943X10.3389/fonc.2021.694664https://doaj.org/article/682895e2e2d84a859f1a0827826e7a6f2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.694664/fullhttps://doaj.org/toc/2234-943XThe last decade has witnessed revolutionary advances taken in immunotherapy for various malignant tumors. However, immune-related molecules and their characteristics in the prediction of clinical outcomes and immunotherapy response in clear cell renal cell carcinoma (ccRCC) remain largely unclear. C-C Motif Chemokine Ligand 4 (CCL4) was extracted from the intersection analysis of common differentially expressed genes (DEGs) of four microarray datasets from the Gene Expression Omnibus database and immune-related gene lists in the ImmPort database using Cytoscape plug-ins and univariate Cox regression analysis. Subsequential analysis revealed that CCL4 was highly expressed in ccRCC patients, and positively correlated with multiple clinicopathological characteristics, such as grade, stage and metastasis, while negatively with overall survival (OS). We performed gene set enrichment analysis (GSEA) and gene set variant analysis (GSVA) with gene sets coexpressed with CCL4, and observed that gene sets positively related to CCL4 were enriched in tumor proliferation and immune-related pathways while metabolic activities in the negatively one. To further explore the correlation between CCL4 and immune-related biological process, the CIBERSORT algorithm, ESTIMATE method, and tumor mutational burden (TMB) score were employed to evaluate the tumor microenvironment (TME) characteristics of each sample and confirmed that high CCL4 expression might give rise to high immune cell infiltration. Moreover, correlation analysis revealed that CCL4 was positively correlated with common immune checkpoint genes, such as programmed cell death protein 1 (PD-1), cytotoxic T-lymphocyte-associated protein 4 (CTLA4), and lymphocyte activating 3 (LAG3). Overall, this study demonstrated that CCL4 might serve as a potential immune-related prognostic biomarker to predict clinical outcomes and immunotherapy response in ccRCC. Moreover, CCL4 might contribute to TME modulation, indicating the mechanism CCL4 involved in tumor proliferation and metastasis, which could provide novel therapeutic perceptions for ccRCC patients.Lu ZhangMengzhao ZhangLu WangJianlong LiTao YangQiuya ShaoXiao LiangMinghai MaNan ZhangMinxuan JingRundong SongJinhai FanJinhai FanFrontiers Media S.A.articleCCL4tumor proliferationimmune infiltrationtumor microenvironmentimmune checkpointsclear cell renal cell carcinomaNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
CCL4 tumor proliferation immune infiltration tumor microenvironment immune checkpoints clear cell renal cell carcinoma Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
CCL4 tumor proliferation immune infiltration tumor microenvironment immune checkpoints clear cell renal cell carcinoma Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Lu Zhang Mengzhao Zhang Lu Wang Jianlong Li Tao Yang Qiuya Shao Xiao Liang Minghai Ma Nan Zhang Minxuan Jing Rundong Song Jinhai Fan Jinhai Fan Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma |
description |
The last decade has witnessed revolutionary advances taken in immunotherapy for various malignant tumors. However, immune-related molecules and their characteristics in the prediction of clinical outcomes and immunotherapy response in clear cell renal cell carcinoma (ccRCC) remain largely unclear. C-C Motif Chemokine Ligand 4 (CCL4) was extracted from the intersection analysis of common differentially expressed genes (DEGs) of four microarray datasets from the Gene Expression Omnibus database and immune-related gene lists in the ImmPort database using Cytoscape plug-ins and univariate Cox regression analysis. Subsequential analysis revealed that CCL4 was highly expressed in ccRCC patients, and positively correlated with multiple clinicopathological characteristics, such as grade, stage and metastasis, while negatively with overall survival (OS). We performed gene set enrichment analysis (GSEA) and gene set variant analysis (GSVA) with gene sets coexpressed with CCL4, and observed that gene sets positively related to CCL4 were enriched in tumor proliferation and immune-related pathways while metabolic activities in the negatively one. To further explore the correlation between CCL4 and immune-related biological process, the CIBERSORT algorithm, ESTIMATE method, and tumor mutational burden (TMB) score were employed to evaluate the tumor microenvironment (TME) characteristics of each sample and confirmed that high CCL4 expression might give rise to high immune cell infiltration. Moreover, correlation analysis revealed that CCL4 was positively correlated with common immune checkpoint genes, such as programmed cell death protein 1 (PD-1), cytotoxic T-lymphocyte-associated protein 4 (CTLA4), and lymphocyte activating 3 (LAG3). Overall, this study demonstrated that CCL4 might serve as a potential immune-related prognostic biomarker to predict clinical outcomes and immunotherapy response in ccRCC. Moreover, CCL4 might contribute to TME modulation, indicating the mechanism CCL4 involved in tumor proliferation and metastasis, which could provide novel therapeutic perceptions for ccRCC patients. |
format |
article |
author |
Lu Zhang Mengzhao Zhang Lu Wang Jianlong Li Tao Yang Qiuya Shao Xiao Liang Minghai Ma Nan Zhang Minxuan Jing Rundong Song Jinhai Fan Jinhai Fan |
author_facet |
Lu Zhang Mengzhao Zhang Lu Wang Jianlong Li Tao Yang Qiuya Shao Xiao Liang Minghai Ma Nan Zhang Minxuan Jing Rundong Song Jinhai Fan Jinhai Fan |
author_sort |
Lu Zhang |
title |
Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma |
title_short |
Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma |
title_full |
Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma |
title_fullStr |
Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma |
title_full_unstemmed |
Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma |
title_sort |
identification of ccl4 as an immune-related prognostic biomarker associated with tumor proliferation and the tumor microenvironment in clear cell renal cell carcinoma |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/682895e2e2d84a859f1a0827826e7a6f |
work_keys_str_mv |
AT luzhang identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT mengzhaozhang identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT luwang identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT jianlongli identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT taoyang identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT qiuyashao identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT xiaoliang identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT minghaima identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT nanzhang identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT minxuanjing identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT rundongsong identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT jinhaifan identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma AT jinhaifan identificationofccl4asanimmunerelatedprognosticbiomarkerassociatedwithtumorproliferationandthetumormicroenvironmentinclearcellrenalcellcarcinoma |
_version_ |
1718406329291243520 |